AB Science announces that it has filed an application for conditional Marketing Authorization to EMA for masitinib in the treatment of ALS
Everything Lubbock,
PRESS RELEASE AB SCIENCE ANNOUNCES FILING OF MARKETING AUTHORIZATION APPLICATION FOR ALSITEK IN THE TREATMENT OF AMYOTROPHIC…